Effect of febuxostat on renal function in patients from South China with CKD3 diabetic nephropathy.
Huang WenZhu YonglingZheng ShuyingWang JialiZhao YanlingPublished in: Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (2021)
Febuxostat can reduce uric acid and improve renal function effectively in patients with CKD stage 3 diabetic nephropathy, while being well tolerated. However, the conclusion is still uncertain due to the short term of the study.